← FDA DRUG APPROVALS

FDA NDA · NDA019822

BIOSCRUB

Sponsor: GRIFFEN

APPLICATION
NDA019822
TYPE
NDA
ORIGINAL APPROVAL
1989-03-31
LATEST ACTION
2018-05-11
ROUTE
TOPICAL
DOSAGE FORM
SPONGE
MARKETING STATUS
Over-the-counter

Products

BIOSCRUBOver-the-counter
CHLORHEXIDINE GLUCONATE 4% · SPONGE · TOPICAL

Approval history

2018-05-11Labeling · Supplement 8 · standard — Letter ↗AP
2013-01-07Labeling · Supplement 7 · standard — Label ↗AP
2003-01-09Labeling · Supplement 6 · standard — Letter ↗AP
1996-02-13Labeling · Supplement 3 · standardAP
1991-04-11Manufacturing (CMC) · Supplement 1 · standardAP
1989-03-31Type 5 - New Formulation or New Manufacturer · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →